✦ LIBER ✦

A phase I dose escalation pharmacokinetic (PK) study of BAY 38-3441 administered as a short infusion once every three weeks

✍ Scribed by K. Mross; U. Sauer; B. Häring; D. Behringer; E. Brendel; C. Unger

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I study of BAY 38-3441 given as

✍ L. Seymour; L. Siu; G. Batist; J. Cammisano; M. Maclean; L. McIntosh; O. Petrenc 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 189 KB

An open-label, dose-escalation, safety,

✍ Murakami, H.; Kurata, T.; Onozawa, Y.; Watanabe, J.; Ono, A.; Takahashi, T.; Yam 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 474 KB

Phase I dose-escalating study of ES-285

✍ C. Massard, R. Salazar, J. P. Armand, M. Majem, E. Deutsch, M. García, A. Oaknin 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 591 KB

550 Phase I and pharmacokinetic (PK) stu

✍ S.Q. Chu; G. Schwartz; M. Beeram; A. Patniak; M. Mita; J. Jimeno; L. Lopez-Laraz 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 273 KB

A phase I and pharmacokinetic study of R

✍ Abigerges, D; Catimel, G; Klink Alakl, M; Bruno, R; Chabot, G; Ardiet, C; Nieman 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 143 KB

A phase I pharmacokinetic study of PM001

✍ J. Capdevila, S. Clive, E. Casado, C. Michie… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 274 KB